Novartis Investigative Site

Merrillville, Indiana 46410

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis

Studies at this site

• Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies — Completed
• A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis — Completed